Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

PaperCitations, authors & open-access status

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 5,921 citations, 2015 year and bronze oa status.

5,921
Citations
2015
Year
bronze
OA Status

Related on ScholarIQ

Toni K. Choueiri
Author
New England Journal of Medicine
Journal
Renal cell carcinoma treatment
Topic
Renal cell carcinoma treatment
Topic
Cancer Immunotherapy and Biomarkers
Topic
Ferroptosis and cancer prognosis
Topic
470M+ articles · free account